- recruitingPHASE3
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
This study is testing a new medicine, VE303, to prevent repeated C. diff infections. C. diff causes severe diarrhoea. We want to see if VE303 is safe and helps stop the infection from coming back after standard treatment.
United States · Australia · Belgium - recruiting
Clostridioides Difficile Infection: Analyzing CLInic Evolution and Bacterial Clearance
This study looks at a common gut infection called Clostridioides difficile (C. diff) in hospital patients. We want to understand why some people get better and others get the infection again. This could help us prevent future infections and improve treatment.
France